VEDOLIZUMAB EXPERIENCE IN CHILDREN AND ADOLESCENTS WITH INFLAMMATORY BOWEL DISEASE: A MULTICENTER OBSERVATIONAL STUDY (VOLCANO)

被引：0
|
作者：
Hajjat, Temara
Mosha, Maua H.
Suppa, Carmine
Markowitz, James
Whaley, Kaitlin G.
Rosen, Michael J.
Shukla-Udawatta, Monica
Boyle, Brendan M.
Hunter, Gabriele
Perez, Maria E.
Hyams, Jeffrey S.
机构：
来源：
GASTROENTEROLOGY | 2019年 / 156卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Mo1796
引用
收藏
页码：S840 / S841
页数：2
相关论文
共 50 条
  • [1] Vedolizumab Experience in Children and Adolescents With Inflammatory Bowel Disease: A Multicenter Observational Study
    Hajjat, Temara M.
    Mosha, Maua
    Whaley, Kaitlin G.
    Rosen, Michael J.
    Suppa, Carmine
    Markowitz, James
    Dufour, Lauren
    Sauer, Cary
    Shukla-Udawatta, Monica
    Boyle, Brendan
    Gibson, Meghan
    Shapiro, Jason
    Sams, Derica
    Sylvester, Francisco
    Hunter, Gabriele
    Perez, Maria E.
    Hyams, Jeffrey S.
    [J]. CROHNS & COLITIS 360, 2021, 3 (03)
  • [2] Effectiveness and safety of vedolizumab in inflammatory bowel disease patients aged 60 and over: an observational multicenter UK experience
    Ibraheim, Hajir
    Samaan, Mark A.
    Srinivasan, Ashish
    Brain, Oliver
    Digby-Bell, Jonathan
    Irving, Peter M.
    Norman, Irena
    Jawad, Issrah
    Biedermann, Julia
    Ibarra, Ana
    Kok, Klaartje Bel
    Parkes, Gareth
    Rimmer, Joanna
    Compot, Elisabeta
    Parkes, Miles
    Segal, Jonathan
    Oppong, Philip
    Hart, Ailsa
    Hayee, Bu'Hussain
    Powell, Nick
    [J]. ANNALS OF GASTROENTEROLOGY, 2020, 33 (02): : 170 - +
  • [3] Correction to: Safety and effectiveness of vedolizumab in paediatric patients with inflammatory bowel disease: an observational multicenter Spanish study
    Ruth Garcia-Romero
    José Miguel Martinez de Zabarte Fernandez
    Gemma Pujol-Muncunill
    Ester Donat-Aliaga
    Oscar Segarra-Cantón
    Iñaki Irastorza-Terradillos
    Enrique Medina-Benitez
    Carlos José Ruiz-Hernández
    Marta Carrillo-Palau
    Ignacio Ros-Arnal
    Alejandro Rodriguez-Martínez
    Laura Escartin-Madurga
    Carolina Gutiérrez-Junquera
    Saioa Vicente-Santamaría
    Marta Velasco Rodriguez-Belvis
    Sonia Fernández-Fernández
    José Ramón Alberto-Alonso
    Montserrat Montraveta
    Ricardo Torres-Peral
    María Navalon-Rubio
    Víctor Manuel Navas-López
    Javier Martin de Carpi
    [J]. European Journal of Pediatrics, 2021, 180 : 3039 - 3040
  • [4] A MULTICENTER COHORT STUDY TO ASSESS THE SAFETY OF VEDOLIZUMAB FOR INFLAMMATORY BOWEL DISEASE
    Meserve, Joseph
    Aniwan, Satimai
    Koliani-Pace, Jenna
    Shashi, Preeti
    Weiss, Aaron
    Faleck, David
    Winters, Adam
    Chablaney, Shreya
    Kochhar, Gursimran
    Boland, Brigid S.
    Singh, Siddharth
    Hirten, Robert
    Shmidt, Eugenia
    Bohm, Matthew
    Sagi, Sashivar
    Fischer, Monika
    Lukin, Dana J.
    Hudesman, David
    Chang, Shannon
    Keith, Sultan
    Swaminath, Arun
    Gupta, Nitin
    Kane, Sunanda V.
    Loftus, Edward V.
    Shen, Bo
    Sands, Bruce E.
    Colombel, Jean Frederic
    Siegel, Corey A.
    Sandborn, William J.
    Dulai, Parambir
    [J]. GASTROENTEROLOGY, 2018, 154 (06) : S361 - S361
  • [5] Vedolizumab is effective and safe in real-life treatment of inflammatory bowel diseases outpatients: A multicenter, observational study in primary inflammatory bowel disease centers
    Tursi, Antonio
    Mocci, Giammarco
    Faggiani, Roberto
    Allegretta, Leonardo
    Della Valle, Nicola
    de Medici, Antonio
    Forti, Giacomo
    Franceschi, Marilisa
    Ferronato, Antonio
    Gallina, Sara
    Grasso, Giuseppina
    Larussa, Tiziana
    Luzza, Francesco
    Lorenzetti, Roberto
    Penna, Antonio
    Rodino, Stefano
    Sebkova, Ladislava
    Lauria, Angelo
    Piergallini, Simona
    Pranzo, Giuseppe
    Scorza, Stefano
    Zampaletta, Costantino
    Picchio, Marcello
    Elisei, Walter
    [J]. EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2019, 66 : 85 - 91
  • [6] VEST: The UK vedolizumab real life experience study in Inflammatory Bowel Disease
    Bodger, K.
    Booker, C.
    Kok, K.
    Lobo, A.
    Ahmad, T.
    Bloom, S.
    Butterworth, J.
    Irving, P.
    Cummings, F.
    [J]. JOURNAL OF CROHNS & COLITIS, 2024, 18 : I1775 - I1777
  • [7] Transition to Subcutaneous Infliximab vs Vedolizumab in Inflammatory Bowel Disease: A Prospective Multicenter Study
    Principi, Mariabeatrice
    Brescia, Irene Vita
    Stasi, Elisa
    Mazzuoli, Silvia
    D'Uggento, Angela Maria
    Equatore, Elena
    Lacavalla, Ilaria
    Di Leo, Alfredo
    [J]. DIGESTIVE DISEASES AND SCIENCES, 2024,
  • [8] Vedolizumab provides clinical benefit over 1 year in patients with active inflammatory bowel disease - a prospective multicenter observational study
    Stallmach, A.
    Langbein, C.
    Atreya, R.
    Bruns, T.
    Dignass, A.
    Ende, K.
    Hampe, J.
    Hartmann, F.
    Neurath, M. F.
    Maul, J.
    Preiss, J. C.
    Schmelz, R.
    Siegmund, B.
    Schulze, H.
    Teich, N.
    von Arnim, U.
    Baumgart, D. C.
    Schmidt, C.
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2016, 44 (11-12) : 1199 - 1212
  • [9] Vedolizumab use after failure of TNF-α antagonists in children and adolescents with inflammatory bowel disease
    Anna-Maria Schneider
    Daniel Weghuber
    Benjamin Hetzer
    Andreas Entenmann
    Thomas Müller
    Georg Zimmermann
    Sebastian Schütz
    Wolf-Dietrich Huber
    Judith Pichler
    [J]. BMC Gastroenterology, 18
  • [10] Vedolizumab use after failure of TNF-α antagonists in children and adolescents with inflammatory bowel disease
    Schneider, Anna-Maria
    Weghuber, Daniel
    Hetzer, Benjamin
    Entenmann, Andreas
    Mueller, Thomas
    Zimmermann, Georg
    Schuetz, Sebastian
    Huber, Wolf-Dietrich
    Pichler, Judith
    [J]. BMC GASTROENTEROLOGY, 2018, 18
12345